2m 2m 2m 2m 2m 2m 2m
MAPLIGHT THERAPE (MPLT)
NASDAQ
$11.21-$0.005 (-0.04%)
Price as of Aug 21, 2026 7:40 PM EDT- $489.3MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
MAPLIGHT THERAPE (MPLT)
$11.21-$0.005 (-0.04%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
NOVO HOLDINGS A/S | 8.69% | 3.7M | 0 (0.00%) | Jun 30, 2026 |
FCPM III SERVICES B.V. | 7.60% | 3.2M | 0 (0.00%) | Jun 30, 2026 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 6.56% | 2.8M | -20,209 (-0.73%) | Jun 30, 2026 |
GOLDMAN SACHS GROUP INC | 4.59% | 1.9M | -46,561 (-2.39%) | Jun 30, 2026 |
PRICE T ROWE ASSOCIATES INC /MD/ | 3.35% | 1.4M | +1.3M (+92.08%) | Jun 30, 2026 |
BLACKROCK, INC. | 2.42% | 1.0M | -314,597 (-30.69%) | Jun 30, 2026 |
NAN FUNG GROUP HOLDINGS LTD | 2.29% | 971,253 | 0 (0.00%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 1.66% | 704,037 | +56,627 (+8.04%) | Mar 31, 2026 |
T. Rowe Price Small-Cap Stock Fund, Inc. | 1.47% | 625,724 | +137,972 (+22.05%) | Mar 31, 2026 |
T. Rowe Price Small-Cap Value Fund, Inc. | 1.46% | 621,328 | -851 (-0.14%) | Mar 31, 2026 |
T. Rowe Price Equity Funds, Inc. | 0.81% | 342,343 | +80,614 (+23.55%) | Mar 31, 2026 |
FIDELITY ADVISOR SERIES VII | 0.48% | 202,900 | +202,900 (+100.00%) | Apr 30, 2026 |
FIDELITY CONCORD STREET TRUST | 0.48% | 202,431 | +37,467 (+18.51%) | May 31, 2026 |
FIDELITY SALEM STREET TRUST | 0.46% | 194,625 | +175,585 (+90.22%) | Apr 30, 2026 |
Current Ownership Distribution
- Institutions74.2M (90.29%)
- Mutual Funds8.0M (9.71%)
- Insiders0 (0.00%)
- Other0 (0.00%)
Insider Transactions
- 0.00% (0)Current InsiderOwnership (%, shares)
- 5Number of InsiderBuying (last 12 months)
- $1.5BAmount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $335.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Foff Erin Pennock Chief Medical Officer | Award | Aug 17, 2026 | $0.00 | 54,240 | $0.00 | 54,240 |
GILLIS JONATHAN CAO and Interim CFO | Award | Aug 17, 2026 | $0.00 | 24,455 | $0.00 | 24,455 |
Lillie James Woodruff Chief Scientific Officer | Award | Aug 17, 2026 | $0.00 | 31,395 | $0.00 | 31,395 |
Hanson Kristopher General Counsel | Award | Aug 17, 2026 | $0.00 | 31,395 | $0.00 | 31,395 |
Kreitzer Anatol Chief Discovery Officer | Award | Aug 17, 2026 | $0.00 | 24,455 | $0.00 | 24,455 |
Kroeger Christopher A. Chief Executive Officer | Award | Aug 17, 2026 | $0.00 | 93,955 | $0.00 | 93,955 |
Lillie James Woodruff Chief Scientific Officer | Award | Aug 17, 2026 | $0.00 | 7,730 | $0.00 | 210,110 |
Hanson Kristopher General Counsel | Award | Aug 17, 2026 | $0.00 | 7,730 | $0.00 | 153,553 |
Foff Erin Pennock Chief Medical Officer | Award | Aug 17, 2026 | $0.00 | 13,360 | $0.00 | 312,261 |
GILLIS JONATHAN CAO and Interim CFO | Award | Aug 17, 2026 | $0.00 | 2,813 | $0.00 | 2,813 |
Kreitzer Anatol Chief Discovery Officer | Award | Aug 17, 2026 | $0.00 | 6,020 | $0.00 | 180,926 |
Kroeger Christopher A. Chief Executive Officer | Award | Aug 17, 2026 | $0.00 | 23,145 | $0.00 | 1.3M |
GILLIS JONATHAN CAO and Interim CFO | Award | Aug 17, 2026 | $0.00 | 6,020 | $0.00 | 150,260 |
GILLIS JONATHAN CAO and Interim CFO | Award | Aug 17, 2026 | $0.00 | 2,222 | $0.00 | 152,482 |
Catalyst4, Inc. | Buy | Aug 14, 2026 | $33.3M | 2.9M | $11.38 | 2.9M |
Catalyst4, Inc. | Buy | Aug 14, 2026 | $50.1M | 4.4M | $11.38 | 25.3M |
Lillie James Woodruff Chief Scientific Officer | Sell | Aug 03, 2026 | $276,908.28 | 22,082 | $12.54 | 202,380 |
Catalyst4, Inc. | Buy | Jul 30, 2026 | $13.0M | 1.0M | $13.00 | 20.9M |
Catalyst4, Inc. | Buy | Jul 29, 2026 | $37,890.00 | 3,000 | $12.63 | 19.9M |
Cox Troy | Buy | Jul 28, 2026 | $148,702.40 | 15,620 | $9.52 | 15,620 |
Catalyst4, Inc. | Buy | Jul 28, 2026 | $1.5M | 141,088 | $10.74 | 19.8M |
Catalyst4, Inc. | Buy | Jul 28, 2026 | $761,392.91 | 65,137 | $11.69 | 19.9M |
Kreitzer Anatol Chief Discovery Officer | Sell | Jul 17, 2026 | $104,962.65 | 2,833 | $37.05 | 189,246 |
Foff Erin Pennock Chief Medical Officer | Sell | Jul 17, 2026 | $138,562.40 | 3,656 | $37.90 | 298,901 |
Kreitzer Anatol Chief Discovery Officer | Sell | Jul 17, 2026 | $533,078.00 | 14,140 | $37.70 | 175,106 |
Hanson Kristopher General Counsel | Sell | Jul 17, 2026 | $42,827.00 | 1,130 | $37.90 | 145,823 |
Kreitzer Anatol Chief Discovery Officer | Sell | Jul 17, 2026 | $7,678.00 | 200 | $38.39 | 174,906 |
Lillie James Woodruff Chief Scientific Officer | Sell | Jul 17, 2026 | $78,718.30 | 2,077 | $37.90 | 224,462 |
Kreitzer Anatol Chief Discovery Officer | Sell | Jul 16, 2026 | $273,630.24 | 7,464 | $36.66 | 193,671 |
Hanson Kristopher General Counsel | Sell | Jul 16, 2026 | $174,085.20 | 4,776 | $36.45 | 150,295 |